2017-03-24,Stocks Under $10 Weekly Summary
2017-03-21,First Week of November 17th Options Trading For Antares Pharma (ATRS)
2017-03-17,Stocks Under $10 Weekly Summary
2017-03-14,Quarter Gives Antares Pharma a 'QuickShot'
2017-03-14,Antares Pharma Reports Fourth Quarter And Full Year 2016 Operating And Financial Results
2017-03-10,Stocks Under $10 Weekly Summary
2017-03-06,Antares Pharma To Report Fourth Quarter And Full Year 2016 Financial And Operating Results And Host Webcast And Conference Call
2017-03-03,Stocks Under $10 Weekly Summary
2017-02-28,Antares Pharma To Present At The Cowen And Company 37th Annual Healthcare Conference
2017-02-27,Antares Pharma Announces FDA Acceptance Of New Drug Application For Quickshot® Testosterone
2017-02-24,Stocks Under $10 Weekly Summary
2017-02-10,Stocks Under $10 Weekly Summary
2017-02-03,Stocks Under $10 Weekly Summary
2017-01-30,Injecting Some Testosterone Into the Portfolio
2017-01-11,2 Bargain Stocks Boasting Big Insider Buys
2016-12-21,Antares Pharma Announces Submission Of New Drug Application For Quickshot® Testosterone
2016-12-20,First Week of August 2017 Options Trading For Antares Pharma (ATRS)
2016-12-19,Antares Pharma Announces The Successful Completion Of Teva's Decentralized Procedure For Teriparatide Injection In Europe
2016-11-23,Antares Pharma To Present At The 28th Annual Piper Jaffray Healthcare Conference
2016-11-10,Antares Pharma To Present At The Jefferies 2016 Global Healthcare Conference
2016-11-09,Antares Pharma Reports Third Quarter 2016 Financial And Operating Results
2016-11-03,Antares Pharma To Report Third Quarter Financial And Operating Results And Host Webcast And Conference Call
2016-11-02,Antares Pharma Announces Presentations At The Sexual Medicine Society Scientific Annual Meeting
2016-10-31,Antares Pharma Appoints Fred M. Powell, Senior Vice President And Chief Financial Officer
2016-10-28,Antares Pharma Announces Multiple Presentations At The Sexual Medicine Society Scientific Annual Meeting
2016-09-22,Antares Pharma Announces Completion Of The QuickShot Testosterone Clinical Program
2016-09-20,Antares Pharma To Present At The Ladenburg Thalmann 2016 Healthcare Conference
2016-09-09,Teva Discusses EpiPen Comps as Host of Generics Unveiled
2016-08-09,Antares Pharma Reports Second Quarter 2016 Operating And Financial Results
2016-08-02,Antares Pharma To Report Second Quarter Financial And Operating Results And Host Webcast And Conference Call
2016-06-27,Teva And Antares Pharma Announce Launch Of Generic Imitrex® In The United States
2016-06-23,Antares Pharma Announces Settlement Of Patent Litigation For Key Alliance Business Product
2016-06-20,ATRS: Insiders vs. Shorts
2016-06-01,Antares Pharma To Present At The Jefferies 2016 Healthcare Conference
2016-06-01,Antares Pharma Announces Update To QuickShot Testosterone Clinical Program
2016-05-12,Short Interest Moves 16.5% Lower For ATRS
2016-05-09,Antares Pharma Reports First Quarter 2016 Operating And Financial Results
2016-05-02,Antares Pharma To Host First Quarter Operating And Financial Results Conference Call
2016-04-27,Antares Pharma To Present At The Deutsche Bank Securities, Inc. 41st Annual Health Care Conference
2016-04-25,OTREXUP.COM Website Awarded A Bronze Horizon Interactive Award
2016-03-29,Additional Dosage Strengths Of Otrexup™ (methotrexate) Injection Approved By FDA
2016-03-24,Insider Trading Alert - ATRS, CMT And CTIC Traded By Insiders
2016-03-22,Insider Trading Alert - FLML, WLFC And ATRS Traded By Insiders
2016-03-21,ATRS: Insiders vs. Shorts
2016-03-16,Antares Pharma Announces Completion Of The 52 Week QuickShot® Phase 3 Study In Testosterone Deficient Men
2016-03-08,Antares Pharma (ATRS) Stock Lower on Q4 Results
2016-03-08,Antares Pharma Reports Fourth Quarter And Full Year 2015 Operating And Financial Results
2016-03-02,Antares Pharma To Present At The Cowen And Company 36th Annual Healthcare Conference
2016-03-01,Antares Pharma To Host Fourth Quarter And Full Year 2015 Operating And Financial Results Conference Call
2016-01-26,Antares Pharma Announces CEO Transition
2016-01-07,Antares Pharma To Present At The 34th Annual J.P. Morgan Healthcare Conference
2015-12-14,Antares Pharma Announces FDA Approval Of Sumatriptan Injection USP
2015-12-06,5 Stocks Under $10 Set to Soar
2015-12-02,Antares Pharma To Present At The 26th Annual Oppenheimer Healthcare Conference
2015-11-20,Antares Pharma Announces Poster Presentation At The Sexual Medicine Society Scientific Annual Meeting
2015-11-09,Antares Pharma Announces Podium Presentation Of OTREXUP™ Dose Conversion Data At American College Of Rheumatology Annual Meeting
2015-11-05,Antares Pharma Reports Third Quarter 2015 Operating And Financial Results
2015-11-03,Antares Pharma Announces Enrollment Complete In Quickshot® Supplemental Safety Study QST-15-005
2015-10-30,Antares Pharma Announces Update To Quickshot Testosterone Clinical Program
2015-10-28,Antares Pharma To Host Third Quarter 2015 Operating And Financial Results Conference Call
2015-09-28,Antares Pharma Announces Publication Of QuickShot® Testosterone Data In Prestigious Health Journal
2015-09-24,Antares Pharma To Present At The Ladenburg Thalmann 2015 Healthcare Conference
2015-08-26,Insider Trading Alert - ATRS, SJW And N Traded By Insiders
2015-08-10,Antares Pharma Reports Second Quarter 2015 Operating And Financial Results
2015-08-04,Antares Pharma Announces First Patients Enrolled In QuickShot® Testosterone Supplemental Safety Study
2015-08-03,Antares Pharma To Host Second Quarter 2015 Operating And Financial Results Conference Call
2015-07-14,Antares Pharma Appoints Peter J. Graham, Esq., Senior Vice President, General Counsel, Human Resources, Chief Compliance Officer And Corporate Secretary
2015-06-29,Drawing Up a Potential Shopping List
2015-06-26,Short Interest Makes 11% Move For ATRS
2015-06-23,First Week Of February 2016 Options Trading For Antares Pharma (ATRS)
2015-06-16,Antares Pharma To Present At The JMP Securities Life Sciences Conference
2015-06-04,Sell These 7 Health Care Supplies Companies Now
2015-06-01,Antares Pharma Announces Additional Update To QuickShot Testosterone Program
2015-05-28,Antares Pharma To Present At The Jefferies 2015 Global Healthcare Conference
2015-05-11,Antares Pharma Announces Closing Of Public Offering Of Common Stock
2015-05-11,Antares Pharma Reports First Quarter 2015 Operating And Financial Results
2015-05-06,Antares Pharma To Present At The Bank Of America Merrill Lynch 2015 Healthcare Conference
2015-05-06,Antares Pharma Announces Pricing Of Public Offering Of Common Stock
2015-05-05,Antares Pharma To Host First Quarter 2015 Operating And Financial Results Conference Call
2015-05-05,Antares Pharma Announces Proposed Public Offering Of Common Stock
2015-04-30,Antares Pharma To Present At The Deutsche Bank Securities, Inc. 40th Annual Health Care Conference
2015-04-27,Antares Pharma Regains U.S. Marketing Rights To OTREXUP For Psoriasis Indication - Announces Termination Of LEO Pharma Marketing Agreement
2015-04-21,First Week Of June 19th Options Trading For Antares Pharma (ATRS)
2015-04-16,Antares Pharma Announces Settlement Of Patent Infringement Lawsuits
2015-04-01,First Week Of November 20th Options Trading For Antares Pharma (ATRS)
2015-03-31,Antares Pharma Announces FDA Approval Of TEV-TROPIN(R) 10 Mg (Human Growth Hormone) Needle-Free Injector
2015-03-25,Insider Trading Alert - GMAN, ATRS And MMI Traded By Insiders
2015-03-12,Antares Pharma Reports Fourth Quarter And Full Year 2014 Operating And Financial Results
2015-03-05,Antares Pharma To Host Fourth Quarter 2014 Operating And Financial Results Conference Call
2015-02-25,Antares Pharma Announces Positive Top-Line Pharmacokinetic Results From The QuickShot® Phase 3 Study In Testosterone Deficient Men
2015-02-23,Antares Pharma To Present At The Cowen And Company 35Th Annual Healthcare Conference
2015-02-18,Antares Pharma To Present At The 2015 RBC Capital Markets' Global Healthcare Conference
2015-02-10,ATRS: Insiders Vs. Shorts
2015-02-09,First Week Of ATRS March 20th Options Trading
2015-01-26,Antares Pharma Provides Regulatory Update On Sumatriptan Injection USP
2015-01-13,Antares Pharma Announces Update To QuickShot® Testosterone Program
2015-01-08,Antares Pharma To Present At The 33rd Annual J.P. Morgan Healthcare Conference
2014-12-24,Interesting ATRS Put Options For August 2015
2014-12-11,Short Interest In Antares Pharma Decreases By 11%
2014-12-03,Antares Pharma To Present At The 25th Annual Oppenheimer Healthcare Conference
2014-11-25,Antares Pharma To Present At The 26th Annual Piper Jaffray Healthcare Conference
2014-11-18,Antares Pharma Appoints James E. Fickenscher, Senior Vice President, Chief Financial Officer
2014-11-06,Antares Pharma Reports Third Quarter 2014 Operating And Financial Results
2014-11-03,Antares Pharma Announces Last Patient Enrolled In Phase 3 QuickShot® Study Evaluating Testosterone-Deficient Adult Males
2014-10-30,Antares Pharma To Host Third Quarter 2014 Operating And Financial Results Conference Call
2014-09-24,Interesting ATRS Call Options For May 2015
2014-09-15,Antares Pharma Announces Promotion Of Robert F. Apple To Chief Operating Officer
2014-09-03,Antares Pharma To Participate At The Morgan Stanley Healthcare Conference
2014-08-28,5 Breakout Stocks Under $10 Set to Soar
2014-08-13,ATRS: Insiders vs. Shorts
2014-08-07,Antares Pharma Reports Second Quarter 2014 Operating And Financial Results
2014-07-31,Antares Pharma To Host Second Quarter 2014 Operating And Financial Results Conference Call
2014-07-22,Antares Pharma Announces First Patient Dosed In Phase 3 QuickShot Study Evaluating Testosterone-Deficient Adult Males
2014-06-25,Interesting ATRS Put Options For February 2015
2014-06-25,Rapid Restoration And Consistent Maintenance Of Steady Blood Levels Achieved With Once-Weekly Subcutaneous Administration Of Testosterone Delivered With A Novel Auto Injector
2014-06-24,Antares Pharma Announces Changes In Senior Leadership
2014-05-28,Antares Pharma To Present At The Jefferies 2014 Global Healthcare Conference
2014-05-22,Antares Pharma Appoints Jennifer Evans Stacey, Esq., Senior Vice President, General Counsel, Human Resources And Secretary
2014-05-20,Interesting ATRS Put Options For July 19th
2014-05-20,Antares Pharma Announces The Publication Of Three Abstracts At The 2014 European League Against Rheumatism Annual Congress
2014-05-13,Antares Pharma To Present At The UBS Global HealthCare Conference
2014-05-09,Antares Pharma Reports First Quarter 2014 Operating And Financial Results
2014-05-07,Antares Pharma To Present At The Bank Of America Merrill Lynch 2014 Healthcare Conference
2014-05-06,Antares Pharma Announces Update To QuickShot Testosterone Program
2014-05-02,Antares Pharma To Host First Quarter 2014 Operating And Financial Results Conference Call
2014-04-24,Antares Pharma To Present At The Deutsche Bank Securities, Inc. 39th Annual Health Care Conference
2014-04-17,Drug-Exposure Limitations Of Oral Methotrexate At Doses Greater Than Or Equal To 15 Mg May Be Overcome With Subcutaneous Administration
2014-04-16,Antares Pharma Announces Additional Patent Coverage For OTREXUP
2014-04-07,Antares Pharma Inc. Stock Downgraded (ATRS)
2014-04-04,Ratings Changes Today
2014-03-26,Interesting ATRS Put And Call Options For November 22nd
2014-03-13,Antares Pharma Reports Fourth Quarter And Full Year 2013 Operating And Financial Results
2014-03-12,Antares Pharma Receives Second Milestone Payment From LEO Pharma In OTREXUP Collaboration
2014-03-11,Medac Pharma, Inc. Announces The Issuance Of U.S. Patent For Treating Autoimmune Diseases With Concentrated Methotrexate Solutions Of More Than 30 Mg/ml
2014-03-10,Antares Pharma Announces LEO Pharma&#8217;s Launch Of OTREXUP (Methotrexate) Injection To Dermatologists For Adults With Psoriasis
2014-03-06,Antares Pharma To Host Fourth Quarter 2013 Operating And Financial Results Conference Call
2014-02-26,First Week Of ATRS April 19th Options Trading
2014-02-26,Antares Pharma To Present At The Cowen And Company 34th Annual Healthcare Conference
2014-02-20,Antares Pharma Announces Positive Results From The VIBEX QuickShot Pharmacokinetic Study In Testosterone Deficient Men
2014-02-19,Antares Pharma To Participate In The 2014 RBC Capital Markets&#8217; Global Healthcare Conference
2014-01-23,Interesting ATRS Call Options For March 22nd
2014-01-15,Antares Pharma Announces Availability Of OTREXUP (Methotrexate) Injection For Subcutaneous Use To Treat Rheumatoid Arthritis (RA) And Psoriasis In Adults, And Polyarticular Idiopathic Arthritis (pJIA) In Children
2014-01-09,Interesting ATRS Call Options For January 18th
2014-01-06,Antares Pharma To Present At The 32nd Annual J.P. Morgan Healthcare Conference
2013-12-27,Antares Pharma (ATRS) Shares Cross Below 200 DMA
2013-12-27,First Week of August 2014 Options Trading For Antares Pharma (ATRS)
2013-12-20,Antares Pharma&#174; Announces Notice Of Allowance For New Patent On Reconstitutable Lyophilized Injectables
2013-12-04,Antares Pharma To Present At The Oppenheimer 24th Annual Healthcare Conference
2013-11-26,Antares Pharma Announces Additional U.S. Patent Protection For OTREXUP&#8482;
2013-11-19,Antares Pharma Appoints David H. Bergstrom Ph.D. As Senior Vice President Pharmaceutical Development
2013-11-15,Antares Pharma To Present At The Jefferies 2013 Global Healthcare Conference
2013-11-14,Antares Pharma Enters Into An Exclusive U.S. Promotion And Marketing Agreement With LEO Pharma For OTREXUP&#8482; In Dermatology
2013-11-06,Antares Pharma Reports Third Quarter 2013 Operating And Financial Results
2013-11-04,Antares Pharma Appoints Dr. Bruce Freundlich As Senior Vice President
2013-10-31,Antares Pharma To Host Third Quarter 2013 Operating And Financial Results Conference Call
2013-10-25,Antares Pharma Announces The Issuance Of A New U.S. Patent On The VIBEX&#174; Device Platform
2013-10-23,First Week Of ATRS December 21st Options Trading
2013-10-16,Antares Announces Podium Presentation Of Pivotal OTREXUP&#8482; (methotrexate) Data At American College Of Rheumatology Annual Meeting
2013-10-14,Antares' Otrexup Approval Was Easy, Selling Drug Will be Hard
2013-10-14,OTREXUP&#8482; (methotrexate) Injection Approved By FDA A New Treatment For Adults With Rheumatoid Arthritis, Children With Polyarticular Idiopathic Arthritis, And Adults With Psoriasis
2013-10-02,Dividend Increases, Research Nominations, New Treatment Options, And Clinical Trials - Research Report On Covidien, Ironwood, ICON, Novadaq, And Antares
2013-10-02,4 Biotech Stocks Under $10 Making Moves
2013-09-26,First Week Of May 2014 Options Trading For Antares Pharma (ATRS)
2013-09-16,Antares Pharma Announces First Patients Dosed In VIBEX&#8482; QS T Study Evaluating Testosterone Deficient Males
2013-08-23,Ratings Changes Today
2013-08-07,3 Stocks Under $10 Moving Higher
2013-08-07,Antares Pharma Reports Second Quarter 2013 Operating And Financial Results
2013-07-31,Antares Pharma To Host Second Quarter 2013 Operating And Financial Results Conference Call
2013-07-30,Antares Pharma Welcomes Robert P. Roche Jr. To Board Of Directors
2013-07-24,First Week Of ATRS September 21st Options Trading
2013-06-28,Biotech Stock Mailbag: Antares Pharma, NewLink, Celgene
2013-06-27,Antares Pharma Announces The Issuance Of A New U. S. Patent For OTREXUP&#8482;
2013-06-13,Subcutaneous, Self-Administered Methotrexate For Rheumatoid Arthritis Demonstrated Significantly Greater Bioavailability Over Current Standard Of Care
2013-05-21,2013 FDA Drug Approval Calendar
2013-04-25,5 Stocks Under $10 Set to Soar
2013-03-13,Antares Pharma Reports Fourth Quarter And Full Year 2012 Operating And Financial Results
2013-03-06,Antares Pharma To Host Fourth Quarter 2012 Call
2013-02-27,Antares Pharma Announces FDA Acceptance Of New Drug Application For OTREXUP&#8482;
2013-02-26,Antares Pharma To Present At The Cowen And Company 33rd Annual Healthcare Conference
2013-02-20,Antares Pharma To Participate In The 2013 RBC Capital Markets&#8217; Healthcare Conference
